- Investing Ideas
- /
- Brazilian Pharmaceuticals & Biotech Undervalued based on future growth
Brazilian Pharmaceuticals & Biotech Undervalued based on future growth
Results
2
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
Hypera
Market Cap: R$15.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$24.03
7D
20.3%
1Y
-15.8%
Blau Farmacêutica
Market Cap: R$2.3b
A pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$12.79
7D
1.0%
1Y
18.5%